<P> Human respiratory syncytial virus ( HRSV ) is a syncytial virus that causes respiratory tract infections . It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood . A prophylactic medication , palivizumab , can be employed to prevent HRSV in preterm ( under 35 weeks gestation ) infants , infants with certain congenital heart defects ( CHD ) or bronchopulmonary dysplasia ( BPD ) , and infants with congenital malformations of the airway . Treatment is limited to supportive care , including oxygen therapy and more advanced breathing support with CPAP or nasal high flow oxygen . </P>
<P> Human respiratory syncytial virus ( HRSV ) is a syncytial virus that causes respiratory tract infections . It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood . A prophylactic medication , palivizumab , can be employed to prevent HRSV in preterm ( under 35 weeks gestation ) infants , infants with certain congenital heart defects ( CHD ) or bronchopulmonary dysplasia ( BPD ) , and infants with congenital malformations of the airway . Treatment is limited to supportive care , including oxygen therapy and more advanced breathing support with CPAP or nasal high flow oxygen . </P>
rsv disease is caused by the respiratory syncytial virus ( rsv ) . rsv is a ( n )
rsv disease is caused by the respiratory syncytial virus ( rsv ) . rsv is a ( n )
syncytial virus
syncytial virus